Completed PHASE3 INTERVENTIONAL 2-arm NCT04438980

Glucocorticoids in COVID-19 (CORTIVID) (CORTIVID)

Treatment of COVID-19 Pneumonia With Glucocorticoids. A Randomized Controlled Trial

Sponsor: Complejo Hospitalario de Navarra

Interventions Methylprednisolone Placebo

Updated 5 times since 2020 Last updated: May 14, 2021 Started: May 15, 2020 Primary completion: Mar 12, 2021 Completion: Apr 9, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Covid-19 Pneumonia and is currently completed. Complejo Hospitalario de Navarra leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jun 2021 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jan 2021 — Jun 2021 [monthly]

Recruiting PHASE3
Jul 2020 — Jan 2021 [monthly]

Recruiting PHASE3

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Complejo Hospitalario de Navarra
Fundacion Miguel Servet
Hospital Sant Joan Despí Moisès Broggi

Data source: Fundacion Miguel Servet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain
• Sant Joan Despí, Spain